Breast Cancer Specialist in Dubai

Breast Cancer Specialist in Dubai - Dr. Ajeet Tiwari

A breast cancer diagnosis usually arrives with a mammogram, an ultrasound, and a biopsy report already in hand, and a recommendation for surgery that can feel rushed before all the options have actually been explained. The two biggest questions patients in Dubai want answered clearly are whether breast-conserving surgery is realistic instead of a full mastectomy, and what the hormone receptor and HER2 results in the pathology report actually mean for the treatment plan that follows.

Dr. Ajeet Tiwari is an MCh surgical oncologist who reviews breast cancer cases for patients in Dubai, explains what the imaging and receptor status findings mean in practical terms, and sets out a comprehensive surgical and systemic treatment plan once the full picture is confirmed.

Book a Consultation

This page walks through both surgical options and systemic therapies, explaining how personalized oncological plans are structured.

Understanding Your Diagnosis: Mammogram, Biopsy and Receptor Testing

Most patients arrive at this stage with a diagnostic mammogram, an ultrasound, and a core needle biopsy already completed, often with estrogen/progesterone receptor and HER2 status included in the immunohistochemistry report. These same reports provide the foundation for a thorough second opinion. An independent evaluation by an experienced surgical oncologist frequently clarifies options, especially regarding how much surgery is genuinely necessary.

Breast Cancer Specialist in Dubai: Comparing Surgical Options

Depending on tumor size, location within the breast tissue, and clinical stage, surgery involves either breast-conserving surgery (lumpectomy)—removing the tumor with a clear margin of healthy tissue while preserving the breast—or a mastectomy, removing the entire breast gland. Both deliver equivalent long-term oncological survival; the selection hinges on achieving negative margins alongside optimal cosmetic and functional outcomes.

Factor	Breast-Conserving Surgery	Mastectomy
What's removed	Tumor plus a clear margin of surrounding healthy breast tissue	The entire breast tissue, including the nipple-areolar complex in standard procedures
Usually followed by	Adjuvant radiotherapy to the remaining breast tissue to minimize local recurrence	Radiotherapy only if specific high-risk features (such as positive nodes or large tumors) are present
Best suited for	Smaller tumors relative to breast volume, unifocal disease, and favorable tumor biology	Larger tumors, multicentric disease, extensive calcifications, or patient preference
Typical hospital stay	Often day-case surgery or an overnight observation stay	Around 2–3 days with surgical drain management

Hormone Receptor and HER2 Status: Why It Matters

The pathology report's receptor status is central to treatment design. It dictates precisely which targeted agents, endocrine therapies, or chemotherapy regimens will effectively eradicate cancer cells.

Receptor Result	What It Means for Treatment
Hormone receptor positive (ER/PR positive)	Endocrine (hormone) therapy forms an integral part of treatment, typically taken orally for 5 to 10 years after surgery to block estrogen stimulation
HER2 positive	Targeted monoclonal antibody therapies (such as Trastuzumab/Pertuzumab) directed specifically against the HER2 protein are added to systemic treatment
Triple-negative (ER, PR, and HER2 negative)	Chemotherapy combined with immunotherapy is the primary systemic treatment, as hormone and HER2-targeted agents are not effective

Axillary Staging: Sentinel Node Biopsy vs Dissection

Assessing whether cancer cells have traversed to the regional axillary lymph nodes is a crucial component of modern breast cancer surgery.

Sentinel Lymph Node Biopsy (SLNB)

This targeted technique isolates and removes only the first few draining lymph nodes using specialized radioisotope or blue dye tracers. If these sentinel nodes are negative on frozen section or histopathology, full axillary clearance is avoided, drastically reducing the lifetime risk of upper-limb lymphedema.

Axillary Lymph Node Dissection (ALND)

When biopsy results or sentinel nodes confirm heavier nodal involvement, a formal axillary lymph node dissection is performed to achieve complete regional disease clearance and guide systemic dosing.

Breast Reconstruction Options

When a mastectomy is clinically necessary, breast reconstruction—performed either immediately during the primary cancer surgery or delayed after completing adjuvant therapies—is thoroughly evaluated. Suitability depends on tumor staging, skin elasticity, radiation requirements, and personal aesthetic goals.

Chemotherapy, Hormone Therapy and Targeted Therapy Sequence

The decision to administer systemic therapies before or after surgery is governed by tumor size, nodal status, and biological subtype determined by immunohistochemistry.

When Chemotherapy Comes Before Surgery (Neoadjuvant)

For locally advanced tumors, triple-negative, or HER2-positive breast cancers, neoadjuvant chemotherapy is frequently administered upfront. This shrinks the tumor, facilitates breast conservation instead of mastectomy, and reveals biological tumor responsiveness in real time.

When Chemotherapy Comes After Surgery (Adjuvant)

For many early-stage, strongly hormone receptor-positive tumors, surgery is performed first. Final histopathology and molecular genomic profiling (such as Oncotype DX) then determine whether post-operative chemotherapy or hormone therapy alone is needed.

Breast Cancer Treatment Cost for Dubai Patients

Overall expenses depend on the surgical procedure required (breast conservation vs. mastectomy), whether immediate oncoplastic reconstruction is performed, and the specific systemic regimen (chemotherapy, targeted biologics, or radiation). A formal, itemized cost estimate is provided after reviewing your pathology and imaging findings.

Breast Cancer Treatment for Patients in Riyadh, Jeddah and Kuwait

The remote surgical consultation process is fully available to patients researching breast oncological management from Riyadh, Jeddah, and Kuwait. Mammograms, breast MRIs, core biopsy reports, and receptor immunohistochemistry profiles can be uploaded securely for review prior to a scheduled video consultation.

How to Get Your Case Reviewed

Send your mammogram reports, breast ultrasound/MRI scans, biopsy histology, and ER/PR/HER2 test results through our second opinion portal. You will receive an oncologist evaluation followed by a video discussion with Dr. Ajeet Tiwari to confirm surgical eligibility and systemic treatment pathways.

Get a Clear Breast Oncology Second Opinion

If you have received a biopsy report or imaging scan and need definitive guidance on breast-conserving surgery, mastectomy, or systemic therapy sequence, submit your records before finalizing treatment decisions.

Request Case Review

Frequently Asked Questions

Find answers to common questions about breast cancer surgery, breast-conserving lumpectomy, mastectomy, HER2 testing, reconstruction, and regional second opinions.

It depends on the tumor size relative to total breast volume, tumor location, and whether disease is confined to a single area (unifocal). Breast-conserving surgery followed by radiation achieves identical survival rates to mastectomy and is evaluated individually after reviewing your mammography and biopsy results.

A HER2 positive result indicates that the cancer cells have an overabundance of the HER2 protein that drives growth. This enables the effective use of targeted anti-HER2 biological medications (such as Trastuzumab), which are combined with surgery and chemotherapy to significantly improve disease-free survival.

The initial diagnostic second opinion and treatment discussion take place via structured video call so that surgical options are clear prior to making travel commitments. If surgery is indicated, operative care is performed at Dr. Tiwari's hospital, with full logistics, inpatient stay, and travel coordination arranged in advance.

Yes, oncoplastic reconstruction—utilizing implants, tissue expanders, or autologous tissue—is discussed during initial surgical planning. The timing (immediate at the time of mastectomy vs. delayed) depends on cancer staging, post-mastectomy radiation plans, and patient preferences.

Cost depends on the scope of surgery (breast conservation vs. mastectomy), whether immediate reconstructive plastic surgery is chosen, and which systemic treatments (chemotherapy or targeted therapy) are indicated by receptor status. A clear, itemized written quotation is provided following record review.

Yes, diagnostic second opinions, imaging evaluations, and surgical coordination are fully accessible to patients connecting from Riyadh, Jeddah, Kuwait, and across the GCC region.